Based on the Kazia Therapeutics Ltd ADR stock forecast from 1 analysts, the average analyst target price for Kazia Therapeutics Ltd ADR is USD 3.00 over the next 12 months. Kazia Therapeutics Ltd ADR’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Kazia Therapeutics Ltd ADR is Bearish, which is based on 1 positive signals and 8 negative signals. At the last closing, Kazia Therapeutics Ltd ADR’s stock price was USD 3.30. Kazia Therapeutics Ltd ADR’s stock price has changed by +328.57% over the past week, +237.80% over the past month and -96.49% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for KZIA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
